Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Early Detection of Cancer clinical trials
6 of 9 indexed Early Detection of Cancer trials are currently recruiting.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · 6 currently recruiting · #1,916 of 28,707 conditions by registered trial count
Early Detection of Cancer: 9 US clinical trials tracked, 6 recruiting.
Early Detection of Cancer is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. The most active sponsor is GRAIL, running 2 of these trials.
Enrollment posture brief
Registry condition early-detection-of-cancer
OPEN 6 | RECR 67% | LATE 0 | EARLY 0 | RANK #1916 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Early Detection of Cancer lists 6 open slots (67% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Early Detection of Cancer on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Early Detection of Cancer is recruiting above its size-band peers.
6 of 9 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Early Detection of Cancer research.
GRAIL accounts for 2 of 9 trials (22.2%). 8 distinct sponsors appear on at least one study for this condition label.
-
Typical Early Detection of Cancer enrolment sits around 14,633 participants.
Median target enrolment is 14,633 among the 9 trials that report a genuine target (sentinel values excluded). 2 of those (22.2%) plan for fewer than 100 participants.
-
Early Detection of Cancer splits between interventional and observational designs.
4 interventional and 5 observational studies make up this index (44.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
9 total, page 1 of 1
Strategic Targeting for Optimal Prevention of Cancer
ClinLogic
NCT03897374
Caris Biorepository Research Protocol
Caris Science
NCT01499394
Avera Cancer Sequencing and Analytics Protocol (ASAP)
Avera McKennan Hospital & University Health Center
NCT05142033
Integrating Telehealth to Advance Lung Cancer Screening
Abramson Cancer Center at Penn Medicine
NCT06638554
The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
Georgetown University
NCT06892275
Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome
Jessica D. St. Laurent, MD
NCT07220239
PATHFINDER 2: a Multi-Cancer Early Detection Study
GRAIL
NCT05155605
REFLECTION: A Clinical Practice Learning Program for Galleri®
GRAIL
NCT05205967
Epigenetic Signature for CRC Early Detection
City of Hope Medical Center
NCT07224854
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Early Detection of Cancer records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Early Detection of Cancer trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Early Detection of Cancer page
9 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Early Detection of Cancer trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- GRAIL sponsors the most Early Detection of Cancer trials on record, review their full trial history before evaluating a specific study. See GRAIL's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Early Detection of Cancer condition card totals 9 registered trials; most-linked intervention Multi-Cancer Early Detection Test; top US site state Louisiana. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.